IPIX (Innovation Pharmaceuticals) Pre-Tax Income: $-2.62 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Innovation Pharmaceuticals Pre-Tax Income?

Innovation Pharmaceuticals IPIX Pre-Tax Income is $-2.62 Mil as of Sep. 2023.

Pretax income is the income that a company earns before paying income taxes. Innovation Pharmaceuticals's pretax income for the three months ended in Sep. 2023 was $-0.88 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.62 Mil. Innovation Pharmaceuticals's pretax margin was %.

Innovation Pharmaceuticals  (OTCPK:IPIX) Pre-Tax Income Explanation

Innovation Pharmaceuticals's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.88/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Pre-Tax Income Related Terms

Innovation Pharmaceuticals Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Pre-Tax Income Chart

Innovation Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.68 -6.65 -13.87 -7.04 -3.17

Innovation Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.43 -0.36 -0.70 -0.68 -0.88

IPIX vs AXIM, RNAZ, APTX: Pre-Tax Income Comparison

For the Biotechnology subindustry, Innovation Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovation Pharmaceuticals Pre-Tax Income vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovation Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Innovation Pharmaceuticals's Pre-Tax Income falls into.


Innovation Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Innovation Pharmaceuticals's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.939+-0.172+-0.057+0+0
=-3.17

Innovation Pharmaceuticals's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.802+-0.064+-0.014+0+1.1102230246252E-16
=-0.88

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of $-2.62 Mil mean?
Innovation Pharmaceuticals (IPIX) has a Pre-Tax Income of $-2.62 Mil as of Sep. 2023. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Pre-Tax Income too high?
Innovation Pharmaceuticals' current Pre-Tax Income is $-2.62 Mil.
How does Innovation Pharmaceuticals' Pre-Tax Income compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Pre-Tax Income of $-2.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Innovation Pharmaceuticals and its competitors. Innovation Pharmaceuticals's current Pre-Tax Income is $-2.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Pre-Tax Income of $-2.62 Mil. The current Pre-Tax Income is $-2.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Pre-Tax Income is $-2.62 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.